NADH Test

Your cells run on a molecular currency you have probably never measured. NADH (nicotinamide adenine dinucleotide, reduced form) is the electron shuttle at the center of how every cell in your body converts food into usable energy. When NADH levels shift out of balance relative to its oxidized partner NAD+, it signals that something fundamental about your cellular metabolism has changed, often years before conventional lab work picks up a problem.

What makes NADH especially interesting from a longevity perspective is that the balance between NADH and NAD+ (known as the redox ratio) touches nearly every age-related disease process: diabetes, heart failure, neurodegeneration, and mitochondrial dysfunction. Measuring NADH gives you a window into your cellular engine room that no standard metabolic panel provides.

What NADH Actually Does in Your Body

NADH is produced in every living cell through the breakdown of food. When your body burns glucose, fats, or amino acids for fuel, it generates NADH as a byproduct. That NADH then carries electrons to the mitochondria (your cell's power plants), where it feeds the electron transport chain and drives the production of ATP, the molecule your cells actually use for energy.

The heart has the highest NAD levels of any organ because of its enormous mitochondrial density and relentless energy demands. But NADH is produced everywhere: the liver generates it during detoxification and fat metabolism, muscles produce it during exercise, and even the brain relies on a constant supply. NAD production rates vary dramatically across tissues, with high turnover in the small intestine and spleen, and relatively low turnover in skeletal muscle.

The ratio between NAD+ and NADH is what matters most clinically. Think of it like a battery: NAD+ is the charged state, ready to accept electrons and do work, while NADH is the spent state, carrying electrons that still need to be processed. A healthy cell keeps this ratio tilted toward NAD+. When NADH accumulates and the ratio shifts, it creates a condition called reductive stress, which paradoxically generates harmful reactive oxygen species and disrupts normal metabolic signaling.

Metabolic Disease and Diabetes

The connection between NADH imbalance and metabolic disease is one of the strongest in the research. In a community-based study of 1,394 adults (the Jidong Community Study), people in the highest quarter of blood NAD levels were about three times as likely to have metabolic disease compared to those in the lowest quarter (OR 3.01, 95% CI 1.87 to 4.87). The relationship was dose-dependent: having three or more metabolic disease components (such as high blood pressure, high blood sugar, and abnormal cholesterol) was associated with over four times the odds (OR 4.30, 95% CI 2.32 to 7.98). These associations held after adjusting for age, sex, drinking, and smoking.

At the cellular level, the mechanism is well understood. When blood sugar runs high, excess glucose floods through alternative metabolic pathways (particularly one called the polyol pathway), generating excessive NADH in both the cytoplasm and mitochondria. This NADH overload disrupts a key protective enzyme family called the sirtuins, impairs the burning of fatty acids, and promotes oxidative stress. The downstream consequences include diabetic nerve damage, heart muscle dysfunction, and kidney disease.

Heart Disease

In the cardiovascular system, a shifted NAD+/NADH ratio contributes to heart failure, damage from blood flow interruptions (ischemia-reperfusion injury), irregular heart rhythms, and high blood pressure. A small but telling study compared 151 healthy blood donors to 19 elderly patients hospitalized for heart failure and found significantly lower blood NAD concentrations in the heart failure group (20.7 vs. 23.4 micromoles per liter). Diabetic cardiomyopathy, a condition where chronically high blood sugar damages the heart muscle, is characterized by a decreased NAD+/NADH ratio and what researchers describe as metabolic rigidity, where the heart loses its ability to flexibly switch between fuel sources.

Aging and NAD+ Decline

NAD+ levels decline with age across multiple tissues, including liver, skin, muscle, pancreas, and fat. This decline is driven by two forces: your body makes less of it (due to reduced activity of a key production enzyme called NAMPT) and consumes more of it (through increased activity of enzymes called PARPs and CD38 that eat through NAD+ during DNA repair and immune responses).

The brain shows a particularly interesting pattern. As you age, brain NADH actually increases while NAD+ decreases, meaning the ratio shifts toward the reduced (NADH-heavy) side. This shift is associated with compromised stress responses, impaired brain plasticity, and cellular aging. Women appear to maintain higher NAD+/NADH ratios than men in younger adulthood, though this sex difference diminishes with biological aging markers like arterial stiffness and skin aging.

Mitochondrial Disease

For people with inherited mitochondrial disorders such as MELAS (a condition causing brain damage, seizures, and metabolic crises) or Leigh syndrome (a severe childhood neurological disease), NADH measurement has a more direct clinical application. Elevated NADH creates what researchers call NADH-reductive stress, and a panel of 20 circulating metabolites that reflect this stress correlates with disease severity better than traditional markers like lactate alone.

These reductive stress markers include compounds like N-lactoyl-amino acids, certain fatty acid derivatives, and the protein GDF-15. While mitochondrial disease is rare, this research has broader implications: the same reductive stress pattern appears in milder forms in common conditions like diabetes and aging, suggesting that NADH measurement may eventually help identify people on a spectrum of mitochondrial dysfunction.

Reference Ranges

There are no consensus clinical reference ranges for NADH, and values vary substantially depending on the sample type and measurement method used. This is one of the most important caveats for anyone ordering this test: you should compare your results within the same lab and assay over time, not against a universal standard. That said, research studies provide some orientation.

Notice the wide range of units and values across these studies. This reflects different measurement technologies, not different populations. A whole-blood enzymatic assay and a plasma fluorescence method are measuring related but not identical things. The most meaningful comparison is always your own value over time using the same test.

In the German plasma study, women had higher NAD+/NADH ratios than men (median 1.33 vs. 1.09), and males had higher absolute NAD levels than females before age 50. The NAD+/NADH ratio appeared more stable across age groups than absolute levels of either molecule alone, which supports the idea that the ratio is a more reliable clinical indicator than raw NADH concentration.

Why a Single Reading Can Fool You

NADH is one of the most technically demanding biomarkers to measure accurately, and several factors can distort a single reading enough to lead you to the wrong conclusion.

• Sample handling: NADH levels can drop by up to 50% within 24 hours unless samples are immediately processed and stored under special conditions. Even the speed of centrifugation and braking method during sample preparation affects results. If your lab does not follow strict protocols, your reading may be artificially low.
• Cell lysis contamination: The concentration of NAD inside your cells is roughly 500 times higher than the concentration floating freely in your blood (131.8 vs. 0.253 micromoles/L). Even trace amounts of red blood cell breakage during the blood draw can dramatically inflate your result.
• Recent intense exercise: Muscle NADH can more than double during high-intensity exercise (from 0.089 to 0.213 mmol/kg at exhaustion), and exercise also changes NAD metabolism in circulating immune cells. Avoid intense workouts for at least 48 hours before testing.
• Circadian rhythm: NAD+ production is regulated by your internal clock, meaning levels fluctuate throughout the day. Test at a consistent time for meaningful comparisons.

Tracking Your Trend

A single NADH reading is a snapshot taken through a foggy window. The real value of this biomarker comes from tracking it over time using the same lab and the same assay. One study demonstrated that individual whole-blood NAD baselines remain stable over 100 days under consistent conditions, which means genuine changes in your trend are likely to reflect real shifts in your metabolic health rather than random noise.

Get a baseline reading, then retest in 3 to 6 months if you are making changes to your diet, exercise, or supplementation regimen. After that, annual testing gives you enough data points to see whether your cellular energy metabolism is holding steady or drifting. If you are supplementing with NAD+ precursors like nicotinamide riboside or NMN, more frequent testing (every 2 to 3 months initially) helps you confirm that your strategy is actually moving the number.

The NAD+/NADH ratio is more informative than either value alone. If your lab reports both, track the ratio as your primary metric. A ratio trending downward over time (more NADH, less NAD+) suggests increasing reductive stress and deserves investigation, even if both individual values remain within published ranges.